These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 17628499)
1. Depleting endogenous neurotrophin-3 enhances myelin formation in the Trembler-J mouse, a model of a peripheral neuropathy. Liu N; Varma S; Tsao D; Shooter EM; Tolwani RJ J Neurosci Res; 2007 Oct; 85(13):2863-9. PubMed ID: 17628499 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of Schwann cell myelin formation by K252a in the Trembler-J mouse dorsal root ganglion explant culture. Liu N; Varma S; Shooter EM; Tolwani RJ J Neurosci Res; 2005 Feb; 79(3):310-7. PubMed ID: 15605381 [TBL] [Abstract][Full Text] [Related]
3. Neurotrophins are key mediators of the myelination program in the peripheral nervous system. Chan JR; Cosgaya JM; Wu YJ; Shooter EM Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14661-8. PubMed ID: 11717413 [TBL] [Abstract][Full Text] [Related]
4. The neurotrophin receptor p75NTR as a positive modulator of myelination. Cosgaya JM; Chan JR; Shooter EM Science; 2002 Nov; 298(5596):1245-8. PubMed ID: 12424382 [TBL] [Abstract][Full Text] [Related]
5. TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in Trembler J mice. Sahenk Z; Galloway G; Edwards C; Malik V; Kaspar BK; Eagle A; Yetter B; Forgie A; Tsao D; Lin JC Exp Neurol; 2010 Aug; 224(2):495-506. PubMed ID: 20553714 [TBL] [Abstract][Full Text] [Related]
6. Trembler as a mouse model of CMT1A? Garbay B; Salles J; Knoll A; Boiron-Sargueil F; Heape AM; Bonnet J; Cassagne C Ann N Y Acad Sci; 1999 Sep; 883():262-72. PubMed ID: 10586251 [TBL] [Abstract][Full Text] [Related]
7. Many facets of the peripheral myelin protein PMP22 in myelination and disease. Naef R; Suter U Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419 [TBL] [Abstract][Full Text] [Related]
8. Nerve conduction abnormalities in the trembler-j mouse: a model for Charcot-Marie-Tooth disease type 1A? Meekins GD; Emery MJ; Weiss MD J Peripher Nerv Syst; 2004 Sep; 9(3):177-82. PubMed ID: 15363066 [TBL] [Abstract][Full Text] [Related]
9. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation. Giambonini-Brugnoli G; Buchstaller J; Sommer L; Suter U; Mantei N Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691 [TBL] [Abstract][Full Text] [Related]
10. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells. Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616 [TBL] [Abstract][Full Text] [Related]
11. NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Sahenk Z; Nagaraja HN; McCracken BS; King WM; Freimer ML; Cedarbaum JM; Mendell JR Neurology; 2005 Sep; 65(5):681-9. PubMed ID: 16157899 [TBL] [Abstract][Full Text] [Related]
12. Developmental loss of NT-3 in vivo results in reduced levels of myelin-specific proteins, a reduced extent of myelination and increased apoptosis of Schwann cells. Woolley AG; Tait KJ; Hurren BJ; Fisher L; Sheard PW; Duxson MJ Glia; 2008 Feb; 56(3):306-17. PubMed ID: 18080292 [TBL] [Abstract][Full Text] [Related]
13. Direct and indirect effects of neuropeptide Y and neurotrophin 3 on myelination in the neonatal brains. Hashimoto R; Udagawa J; Kagohashi Y; Matsumoto A; Hatta T; Otani H Brain Res; 2011 Feb; 1373():55-66. PubMed ID: 21167823 [TBL] [Abstract][Full Text] [Related]
14. Localization of TrkC to Schwann cells and effects of neurotrophin-3 signaling at neuromuscular synapses. Hess DM; Scott MO; Potluri S; Pitts EV; Cisterni C; Balice-Gordon RJ J Comp Neurol; 2007 Apr; 501(4):465-82. PubMed ID: 17278135 [TBL] [Abstract][Full Text] [Related]
15. BDNF overexpression produces a long-term increase in myelin formation in the peripheral nervous system. Tolwani RJ; Cosgaya JM; Varma S; Jacob R; Kuo LE; Shooter EM J Neurosci Res; 2004 Sep; 77(5):662-9. PubMed ID: 15352212 [TBL] [Abstract][Full Text] [Related]
16. Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathies. Zielasek J; Toyka KV Ann N Y Acad Sci; 1999 Sep; 883():310-20. PubMed ID: 10586256 [TBL] [Abstract][Full Text] [Related]
17. Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model. Fortun J; Li J; Go J; Fenstermaker A; Fletcher BS; Notterpek L J Neurochem; 2005 Mar; 92(6):1531-41. PubMed ID: 15748170 [TBL] [Abstract][Full Text] [Related]
18. Trembler mouse carries a point mutation in a myelin gene. Suter U; Welcher AA; Ozcelik T; Snipes GJ; Kosaras B; Francke U; Billings-Gagliardi S; Sidman RL; Shooter EM Nature; 1992 Mar; 356(6366):241-4. PubMed ID: 1552943 [TBL] [Abstract][Full Text] [Related]
19. Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele. Adlkofer K; Naef R; Suter U J Neurosci Res; 1997 Sep; 49(6):671-80. PubMed ID: 9335255 [TBL] [Abstract][Full Text] [Related]
20. Expression pattern of the peripheral myelin protein 22kDa (PMP22) in neural and non-neural tissue types of adult wildtype and Trembler mice--a comparative study. Rautenstrauss B; Zechner U; Hameister H; Grehl H; Liehr T J Peripher Nerv Syst; 1998; 3(2):117-24. PubMed ID: 10959245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]